Eicosapentaenoic Acid | CAS:10417-94-4

We serve Eicosapentaenoic Acid CAS:10417-94-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Eicosapentaenoic Acid

Chemical Name: Eicosapentaenoic Acid
Synonyms:all cis-5,8,11,14,17-Eicosapentaenoic Acid
Ropufa 70
TIMNODONIC ACID
eicosapentenoic acid
 
CAS.NO: 10417-94-4
Molecular Formula: C20H30O2
Molecular Weight: 302.45100
 
Physical and Chemical Properties:
Density: 0.941 g / cm3
Boiling point: 439.3ºC at 760 mmHg
Melting point: -54–53ºC (lit.)
Flash point: 336ºC
Refractive index: n20 / D 1.4977 (lit.)
 
Specification:
Appearance: liquid
Purity:≥99%
 
Packing:1kg / 5KG / aluminum bottle, filled with nitrogen
Storage:-20 ° C refrigerated, sealed, dry place
Application:EPA has the effects of lowering blood lipids, lowering blood pressure and lowering blood sugar, and can prevent and improve arteriosclerosis and prevent hypertension. However, in the prevention and treatment of cardiovascular diseases, side effects such as gastrointestinal upset, pulmonary embolism, skin reactions, and agranulocytosis may occur.



Contact us for information like Eicosapentaenoic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,eicosapentenoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,eicosapentenoic acid Use and application,Eicosapentaenoic Acid technical grade,usp/ep/jp grade.


Related News: Active pharmaceutical ingredients directly impact disease.6-Chloro-5-methylpyridin-3-amine manufacturer Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzaldehyde supplier “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.4,6-Dichloro-5-nitro-2-(propylthio)pyrimidine vendor The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.